Newron Pharmaceuticals S.p.A.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Newron Pharmaceuticals S.p.A.'s balance sheet done over the years? Its assets were worth $25,866,000 last year, which is less than in the previous period. 216% of Newron Pharmaceuticals S.p.A.’s total assets is currently financed by debt. Its liabilities reached the amount of $55,774,000, which means an increase by 9% compared compared to last year.
Debt to Assets
| 2014 | 37074000 | 7.81M | 21.07% |
|---|---|---|---|
| 2015 | 44380000 | 7.26M | 16.38% |
| 2016 | 56591000 | 6.84M | 12.09% |
| 2017 | 73024000 | 5.30M | 7.26% |
| 2018 | 59999000 | 5.16M | 8.61% |
| 2019 | 60288000 | 23.49M | 38.96% |
| 2020 | 51198000 | 33.95M | 66.32% |
| 2021 | 50486000 | 47.37M | 93.85% |
| 2022 | 37195000 | 51.22M | 137.72% |
| 2023 | 25866000 | 55.77M | 215.63% |
NWRN.SW Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 6.33M | 13.42M | 25.01M | 13.21M | 22.05M | 27.62M | 40.64M | 42.94M | 36.01M | 18.75M |
Short term investments | 6.26M | 9.35M | 9.57M | 18.03M | 17.11M | 16.23M | 19.43M | 3.52M | 4.92M | 6.94M |
Net receivables | 2.02M | 1.94M | 1.30M | 6.62M | 1.74M | 1.24M | 1.06M | 1.32M | 1.21M | 2.71M |
Inventory | 0 | 1 | 0 | 0 | 1 | 1 | 5K | 5K | 38K | 102K |
Other current assets | 5.03M | 3.77M | 3.52M | 2 | 4.57M | 14.41M | 11.64M | 8.33M | 1.78M | 874K |
Total current assets | 19.65M | 28.49M | 39.42M | 37.87M | 45.49M | 59.51M | 72.8M | 56.14M | 43.97M | 29.38M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 405K | 527K | 577K | 734K | 252K | 374K | 107K | 120K | 79K | 67K |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 2K | 11K | 20K | 30K | 35K | 261K | 265K | 6.99M |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 584K |
Other non-current assets | 5.80M | -527K | -579K | -745K | -272K | -404K | -142K | -381K | -344K | -7.64M |
Total non-current assets | 6.21M | 527K | 579K | 745K | 272K | 404K | 142K | 381K | 344K | 7.64M |
Total assets | 25.86M | 37.19M | 50.48M | 51.19M | 60.28M | 59.99M | 73.02M | 56.59M | 44.38M | 37.07M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | -172K | -150K | -151K | -60K | 0 | 0 | -364K | -362K | -358K |
Short term debt | 22.45M | 172K | 150K | 151K | 60K | 0 | 0 | 364K | 362K | 358K |
Total current liabilities | 28.92M | 5.04M | 3.65M | 6.89M | 5.59M | 4.43M | 4.72M | 6.64M | 6.51M | 4.48M |
| Non-current liabilities: | ||||||||||
Long term debt | 25.96M | 45.16M | 42.54M | 25.67M | 16.74M | 0 | 0 | 0 | 364K | 729K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 885K | -45.16M | -42.54M | -25.67M | -16.74M | 0 | 576K | 124K | 0 | 0 |
Total non-current liabilities | 26.84M | 45.16M | 42.54M | 25.67M | 16.74M | 606K | 576K | 199K | 364K | 729K |
Total liabilities | 55.77M | 51.22M | 47.37M | 33.95M | 23.49M | 5.16M | 5.30M | 6.84M | 7.26M | 7.81M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |